Biomarin Pharmaceutical Inc. Retirement Savings Plan — Form 5500 plan (Biomarin Pharmaceutical Inc.)

Plain-English plan summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Biomarin Pharmaceutical Inc. Retirement Savings Plan is a benefit plan reported by Biomarin Pharmaceutical Inc. under EIN 68-0397820 and plan number 001. The latest loaded filing year is 2023. The filing reports 3,178 participants and $616,847,325 in end-of-year plan assets, where available in the loaded dataset.

Key reported metrics

Plan sponsor
Biomarin Pharmaceutical Inc.
EIN
68-0397820
Plan number
001
Plan type
2
Location
Novato, CA
Latest filing year
2023
Participants
3,178
End-of-year plan assets
$616,847,325

Form 5500 filing history

Filings loaded for this plan
Filing yearParticipantsSchedulesFiling
20233,178H, C20241011171830NAL0045269330001

Reported financial statement (2023 · Schedule H)

Net assets

Total assets (EOY)
$616,847,325
Net assets (EOY)
$616,847,325
Net assets (BOY)
$494,415,032

Income & contributions

Employer contributions
$24,916,499
Participant contributions
$36,647,661
Total contributions
$66,898,064
Total income / additions
$168,724,694

Expenses & distributions

Benefits paid
$46,202,156
Administrative expenses
$50,285
Total expenses
$46,292,401
Net increase / (decrease)
$122,432,293

Service provider compensation (Schedule C)

Reported service provider compensation
ProviderServiceDirect comp.Indirect comp.Year
Dynamic Wealth AdvisorsNONE$9,709not reported in the loaded dataset2023
Summitry LLCNONE$8,748not reported in the loaded dataset2023
Schwab Retirement Plan Services,IncNONE$6,900not reported in the loaded dataset2023
Creative Planning LLCNONE$6,533not reported in the loaded dataset2023
Abound Wealth Management LLCNONE$5,308not reported in the loaded dataset2023
Charles Schwab & Co., IncNONE$1,530$02023

Related Form 5500 pages